ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

Fujifilm joins Gates Foundation coronavirus treatment initiative

Denmark subsidiary's facility to produce drug supplies for low-income countries

Tokyo -- Fujifilm Diosynth Biotechnologies is allocating manufacturing capacity at its Denmark facility to develop coronavirus treatments with the COVID-19 Therapeutics Accelerator led by the Bill and Melinda Gates Foundation.

Diosynth Biotechnologies is a subsidiary of Fujifilm Holdings, which also produces Avigan, the flu medication said to be effective in treating the novel coronavirus.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more